Swedish Orphan Biovitrum AB

66
Hold
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0000872095
SEK
343.00
5.2 (1.54%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Swedish Orphan Biovitrum AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
4,407.00
2,954.00
3,321.00
3,295.00
4,217.00
4,247.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-180.00
-1,161.00
-807.00
1,114.00
-184.00
-1,666.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
7,387.00
4,470.00
4,665.00
5,470.00
5,214.00
3,634.00
Cash Flow from Investing Activities
-3,075.00
-21,904.00
-1,477.00
-367.00
-3,964.00
-21,685.00
Cash Flow from Financing Activities
-4,016.00
17,012.00
-2,991.00
-4,474.00
-1,570.00
15,780.00
Net Cash Inflow / Outflow
235.00
-457.00
316.00
641.00
-333.00
-2,262.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-61.00
-35.00
119.00
12.00
-13.00
9.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Swedish Orphan Biovitrum AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
4407
-189.519
4,596.00
2425.36%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-180
-62.57
-118.00
-187.68%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
7387
-316.332
7,703.00
2435.20%
Cash Flow from Investing Activities
-3075
205.633
-3,280.00
-1595.38%
Cash Flow from Financing Activities
-4016
5.686
-4,021.00
-70729.62%
Net Cash Inflow / Outflow
235
-98.639
333.00
338.24%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-61
6.374
-67.00
-1057.01%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 65.26% vs -4.18% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
7,387.00
4,470.00
65.26%